top of page

Infectious Disease & Sepsis

Public·487 members

Topics

ardifkui

I completed Recognition & Identification!

84 Views

Mazen Kherallah

Mazen Kherallah

Hour-1 Bundle

78 Views

Mazen Kherallah

Mazen Kherallah

Hour-1 Bundle!

69 Views

Mazen Kherallah

Mazen Kherallah

December 30, 2024

A phase III randomized controlled non-inferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) versus piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) - International Journal of Infectious Diseases

96 Views

About

Welcome to the group! Connect with other members, get updates and share media.

Members

Abdullah
drkasgov
Nader Guma
Salah Safieldeen
Pioneer
Mahir Al Bahrani

See All Members (487)

Topics

bottom of page